CBLL1 and malignant colon neoplasm: In a tumorsphere in vitro model, the silencing of Hakai with a specific shRNA-CBLL1 resulted in reduced tumorsphere number and sizes, together with the downregulation of Lgr5, probably the best established colon cancer stem cell marker, and Nanog and Klf4, universal CSC markers, at the protein level [75].